Av
Life science-bolaget Biotech Igg meddelade i början av året att de skulle lägga ner sin verksamhet i Storbritannien för att istället fokusera på försäljning i Norden via bolagets verksamheter i Sverige och Danmark. Alla leverantörskontrakt på den brittiska marknaden kommer nu att avslutas.
Biotech Igg utvecklar och säljer produkter och konsulttjänster för forskning, produktion och analyser av proteiner, framförallt antikroppar. Tidigare hette moderbolaget Chemel och säljorganisationen Biotech Igg, men i juli 2011 bytte moderbolaget namn till Biotech Igg.
Bolaget har haft en ekonomisk tuff situation under året och har sedan 2010 genomfört sex emissioner i hopp om att få in kapital till verksamheten. Den senaste, som avslutades i november, tecknades till 33 procent, ett utfall som låg i linje med de tidigare fem emissionerna. Genom novemberemissionen fick bolaget in 1,1 miljoner kronor före emissionskostnaderna som uppskattades till 250 000 kronor.
Den 3 februari håller bolaget en extra bolagsstämma där aktieägarna ska ta ställning till om ytterligare en emission ska genomföras framöver. Styrelsen vill ta in högst två miljoner kronor genom att släppa högst 40 miljoner B-aktier. Syftet är att få in kapital till bolagets försäljnings- och marknadsaktiviteter.
Biotech Igg utvecklar och säljer produkter och konsulttjänster för forskning, produktion och analyser av proteiner, framförallt antikroppar. Tidigare hette moderbolaget Chemel och säljorganisationen Biotech Igg, men i juli 2011 bytte moderbolaget namn till Biotech Igg.
Bolaget har haft en ekonomisk tuff situation under året och har sedan 2010 genomfört sex emissioner i hopp om att få in kapital till verksamheten. Den senaste, som avslutades i november, tecknades till 33 procent, ett utfall som låg i linje med de tidigare fem emissionerna. Genom novemberemissionen fick bolaget in 1,1 miljoner kronor före emissionskostnaderna som uppskattades till 250 000 kronor.
Den 3 februari håller bolaget en extra bolagsstämma där aktieägarna ska ta ställning till om ytterligare en emission ska genomföras framöver. Styrelsen vill ta in högst två miljoner kronor genom att släppa högst 40 miljoner B-aktier. Syftet är att få in kapital till bolagets försäljnings- och marknadsaktiviteter.
"Uppsala BIO is a life science pathfinder. We build ways to make life science flourish, in cooperation with industry, academia, society and healthcare." 
"Our aim is to be the best drug development partner to the biotechnology and pharmaceutical industry no matter where you are based." 
"Allenex is a life science company that develops, manufactures, markets and sells high quality products for the transplantation market." 
"Anton Paar is a product and service leader in the field of scientific instruments. We deliver uncompromised quality in everything we do." 
"We aim to be the pioneering benchmark in user-friendly software experience in combination with the highest level of quality." 
"Discover your possibilities in one of Europe´s most productive life science regions. Welcome to Stockholm-Uppsala."
" 
"To supply Swedish and Danish laboratories with laboratory equipment and furniture of highest quality and offer service on all delivered products." 
"PCG - a professional full service CRO for your clinical trials.
Powered by Viedoc, globally trusted eCRF, keeping trials within budget and timelines" 
"Dilafor is developing new products in the field of obstetrics, to provide an effective solution to the challenge of dystocia or protracted labor"
" 
"Your work is important to us, we are committed to your success.
Innovative tools? Please download the Promega app." 
"APL provides high-quality services to Life Science. We are a Dedicated Partner from Discovery to Market." 
"To be the most attractive node and business platform in the Nordic countries for new and innovative Life Science companies" 
"We offer effective staffing solutions provided by specialists, we understand a company’s specific needs and we know where to find the best talent." 
"We are entirely devoted to luminescence technology." 
"Medivir is a specialty pharmaceutical company with unique positioning on the Nordic market and our goal is become a profitable company in high growth" 
"Our reliability, customer service, global network and integrated technology make World Courier service truly "A service no one else can deliver"." 
"We help our clients create significant business value through scientific expertise." 
"Our goal is to invest in innovations and develop new unique pharmaceuticals" 
"The PolyPeptide Group is a world class manufacturer of peptide active pharmaceutical ingredients." 
"TFS is today the leading European development partner for biopharmaceutical companies in their global clinical development process." 
"Our services in ligand-based and structure-based drug design is a cost-efficient alternative for smaller pharmaceutical companies" 
"Mercodia has been a supplier of reliable assays since 1991" 
"We are making it more attractive for companies to invest in innovation with reduced corporation tax on profits from patents to 10%." 
"Best in class companies see the value of optimising their business by having an effective strategy for information management and documentation." 
"We turn medical research into applications for better health and well-being." 
"Your global partner of pharmaceutical service and cGMP manufacturing" 
"We are recognized as a flexible partner with short decision and lead times plus a proven record for the highest quality and cost efficiency." 
"Novel products for CVD treatment and prevention." 
"We have a unique technological platform, built around 5HT-receptor antagonism, for the treatment of inflammation and pain"." 
"Together with Zacco our clients achieve their business goals through the management of their intellectual property." 
"Innovation takes place when biology meets engineering; ICT is an enabler to solve the needs for increased functionality and reduced cost in Life Science" 
"Our products enable an increased number of transplants leading to substantial cost savings for society and increased quality of life for patients." 
"Our vision is to become one of the top 10 global providers of scientific instruments; we will get there by striving for market leadership in our respective product and application niches."
" 
"With our first class products and our committed and skilled colleagues we guarantee our customers the best support in the market, at no extra charge." 
"Our organisation value is to contribute to positioning Scandinavian healthcare and research in absolute world class." 
"VWR is a global laboratory distributor of chemicals, life science products, consumables, equipment, instruments, furniture, e-commerce and services" 
"We promise to go the extra mile every day to ensure you receive the highest level of service and value with each shipment you entrust to us." 
"To become an internationally leading dental company with innovative, proprietary products of high therapeutic and commercial value." 
"To develop innovative and effective pharmaceuticals within autoimmune/ inflammatory diseases and cancer where major medical need exists" 
"As a full service CRO with offices in all Nordic countries we can provide our customer with professional support throughout the clinical research." 
"To be acknowledged as the Best-in-Class provider of pharmaceutical development and manufacturing services by customers, employees & other stakeholders" 
"To adapt Competent Authorities´ requirements into opportunities is not just an artform - today it´s a business necessity." 
